Xin‐Rong Yang
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer Genomics and Diagnostics 27
- Cancer, Hypoxia, and Metabolism 10
- Cancer-related molecular mechanisms research 9
- Oncology 48
- Cancer Cells and Metastasis 20
- Co-authors
- Jia Fan (111 shared papers)Jian Zhou (61 shared papers)Shuang–Jian Qiu (33 shared papers)Yun‐Fan Sun (42 shared papers)Yang Xu (26 shared papers)Bo Hu (43 shared papers)Wei Guo (26 shared papers)Xin Zhang (8 shared papers)
In The Last Decade
Xin‐Rong Yang
175 papers receiving 9.6k citations
Xin‐Rong Yang's Hit Papers
Peers
Comparison fields: 5 of 136
- Hepatology 1.4k
- Cancer Research 2.3k
- Oncology 2.9k
- Immunology 942
- Molecular Biology 2.9k
Countries citing papers authored by Xin‐Rong Yang
This map shows the geographic impact of Xin‐Rong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin‐Rong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin‐Rong Yang more than expected).
Fields of papers citing papers by Xin‐Rong Yang
This network shows the impact of papers produced by Xin‐Rong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin‐Rong Yang. The network helps show where Xin‐Rong Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin‐Rong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma Hit paper breakdown → | 2014 | 1663 |
| 2 | Targeted therapy for hepatocellular carcinoma Hit paper breakdown → | 2020 | 531 |
| 3 | 2017 | 437 | |
| 4 | Th17 and natural Treg cell population dynamics in systemic lupus erythematosus Hit paper breakdown → | 2009 | 394 |
| 5 | 2012 | 343 | |
| 6 | 2010 | 239 | |
| 7 | 2018 | 215 | |
| 8 | Fluorescent probes for the detection of disease-associated biomarkers Hit paper breakdown → | 2022 | 212 |
| 9 | 2019 | 197 | |
| 10 | 2019 | 169 | |
| 11 | 2011 | 154 | |
| 12 | 2018 | 153 | |
| 13 | 2008 | 137 | |
| 14 | 2018 | 137 | |
| 15 | 2009 | 133 | |
| 16 | 2008 | 129 | |
| 17 | 2017 | 127 | |
| 18 | 2011 | 125 | |
| 19 | 2009 | 123 | |
| 20 | 2010 | 111 |
About Xin‐Rong Yang
Xin‐Rong Yang is a scholar working on Cancer Research, Oncology, Molecular Biology, Hepatology and Pulmonary and Respiratory Medicine, having authored 179 papers that have together received 9.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Cancer Genomics and Diagnostics (27 papers), Cancer Cells and Metastasis (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Cancer Mechanisms and Therapy (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Ferroptosis and cancer prognosis (10 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Hepatology (1.4k citations), Cancer Research (2.3k citations), Oncology (2.9k citations), Immunology (942 citations) and Molecular Biology (2.9k citations). Xin‐Rong Yang has collaborated with scholars based in China, Ethiopia and India. Frequent co-authors include Jia Fan, Jian Zhou, Shuang–Jian Qiu, Yun‐Fan Sun, Yang Xu, Bo Hu, Wei Guo, Xin Zhang, Ao Huang and Jian Zhou. Their work appears in journals such as Journal of Clinical Oncology, Hepatology, Clinical Cancer Research, Clinical and Translational Medicine and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.